IVPR vs RYM
Inspire Veterinary Partners, Inc. and Rythm, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | IVPR | RYM |
|---|---|---|
| Revenue | $16.6M | $17.3M |
| Net income | $-14.3M | $-33.3M |
| Gross margin | · | · |
| Net margin | −86.0% | · |
| Return on equity | · | −161.8% |
| Diluted EPS | · | −$16.68 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $-10.2M | · |
| Equity | $1.6M | $13.0M |
| Net debt / equity | 7.34× | −1.81× |
| Current ratio | 0.25× | 1.11× |
| Revenue CAGR 5y | · | · |
| Profit CAGR 5y | · | · |
IVPR and RYM book revenue within 15% of each other, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
Revenue by year
3 years side by side
| Fiscal year | IVPR | RYM |
|---|---|---|
| FY2024 | $16.6M | $18,000 |
| FY2023 | $16.7M | $15.1M |
| FY2022 | $9.8M | $58.3M |
Net income by year
Bottom line
| Fiscal year | IVPR | RYM |
|---|---|---|
| FY2024 | $-14.3M | $-41.7M |
| FY2023 | $-14.8M | $-18.6M |
| FY2022 | $-4.9M | $-188.2M |